Bank of New York Mellon
OPRX icon

Bank of New York Mellon’s OptimizeRx OPRX Stock Holding History

Bank of New York Mellon’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Sell
64,707
-37,667
-37% -$217K ﹤0.01% 3891
2026
Q1 		$643K Sell
102,374
-11,884
-10% -$110K ﹤0.01% 3471
2025
Q4 		$1.4M Buy
114,258
+26,301
+30% +$430K ﹤0.01% 3051
2025
Q3 		$1.8M Sell
87,957
-1,820
-2% -$28.9K ﹤0.01% 2852
2025
Q2 		$1.21M Buy
89,777
+239
+0.3% +$2.61K ﹤0.01% 3024
2025
Q1 		$775K Buy
89,538
+1,826
+2% +$11.2K ﹤0.01% 3198
2024
Q4 		$426K Sell
87,712
-8,436
-9% -$47.1K ﹤0.01% 3609
2024
Q3 		$742K Sell
96,148
-15,571
-14% -$138K ﹤0.01% 3300
2024
Q2 		$1.12M Buy
111,719
+10,041
+10% +$110K ﹤0.01% 3130
2024
Q1 		$1.24M Sell
101,678
-4,630
-4% -$67.1K ﹤0.01% 3035
2023
Q4 		$1.52M Buy
106,308
+1,223
+1% +$11.7K ﹤0.01% 2965
2023
Q3 		$818K Sell
105,085
-2,052
-2% -$22.3K ﹤0.01% 3281
2023
Q2 		$1.53M Sell
107,137
-10,918
-9% -$155K ﹤0.01% 2977
2023
Q1 		$1.73M Sell
118,055
-86,071
-42% -$1.44M ﹤0.01% 2883
2022
Q4 		$3.43M Buy
204,126
+46,608
+30% +$806K ﹤0.01% 2553
2022
Q3 		$2.33M Sell
157,518
-22,098
-12% -$437K ﹤0.01% 2748
2022
Q2 		$4.92M Buy
179,616
+986
+0.6% +$29.2K ﹤0.01% 2311
2022
Q1 		$6.74M Buy
178,630
+13,725
+8% +$607K ﹤0.01% 2268
2021
Q4 		$10.2M Buy
164,905
+78,536
+91% +$5.95M ﹤0.01% 2087
2021
Q3 		$7.39M Buy
86,369
+40,783
+89% +$2.56M ﹤0.01% 2289
2021
Q2 		$2.82M Buy
45,586
+2,651
+6% +$135K ﹤0.01% 2788
2021
Q1 		$2.09M Sell
42,935
-285
-0.7% -$13.8K ﹤0.01% 2899
2020
Q4 		$1.35M Buy
43,220
+2,436
+6% +$59.7K ﹤0.01% 3079
2020
Q3 		$850K Sell
40,784
-445
-1% -$7.64K ﹤0.01% 3216
2020
Q2 		$537K Sell
41,229
-975
-2% -$10.6K ﹤0.01% 3437
2020
Q1 		$382K Sell
42,204
-992
-2% -$9.41K ﹤0.01% 3499
2019
Q4 		$443K Buy
43,196
+5,473
+15% +$62K ﹤0.01% 3648
2019
Q3 		$547K Buy
37,723
+7,602
+25% +$118K ﹤0.01% 3485
2019
Q2 		$488K Buy
+30,121
New +$407K ﹤0.01% 3619

Other funds holding OPRX

RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 46.14% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Bank of New York Mellon's OPRX Position: Q2 2026 in Review

Bank of New York Mellon reduced its OptimizeRx (OPRX) stake by 37% in Q2 2026, selling an estimated $217K and leaving 64,707 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #3891.

Bank of New York Mellon first reported a position in OPRX in Q2 2019 and has held it in 29 quarters since. The position peaked at $10.2M in Q4 2021. 44 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Bank of New York Mellon held 64,707 shares of OptimizeRx worth $370K as of Q2 2026.
  • Bank of New York Mellon sold 37,667 OptimizeRx shares in Q2 2026, an estimated $217K.
  • OptimizeRx made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3891 holding.
  • Bank of New York Mellon first reported a position in OptimizeRx in Q2 2019 and has held it in 29 quarters since.
  • Bank of New York Mellon's OptimizeRx position peaked at $10.2M in Q4 2021.
  • 44 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.